Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta

Feature Writer

B.Sc. Physiology, M.Sc. Physiology, Ph.D. Physiology

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world.

Since she was very young, Dr. Dutta was passionate about the world of science and making it accessible to all. During her time at school, Dr. Dutta particularly enjoyed taking part in biology experiments in the laboratory. The inner workings and diversity of the human body used to surprise her every day and eventually inspired her to become a biologist.

In order to learn more about the subject, Sanchari decided to take biology as her main subject at university and gained Bachelor of Science (B.Sc.) and Master of Science (M.Sc.) degrees in human physiology from the University of Calcutta, India.

This was followed by a Ph.D., also in physiology. During her tenure (2004 – 2010), she received the ‘Surg. Rear Admiral M.S. Malhotra Research Prize’ for best publication from the Defence Institute of Physiology and Allied Sciences, India.

Her thirst for knowledge and dream to be a science writer were always abreast throughout her academic tenure. However, instead of starting her career as a writer straight away, Sanchari decided to further her knowledge of the molecular biology of the human body and carried out postdoctoral research for 6 years after her Ph.D.

During this period, Dr. Dutta received ‘Dean of Faculty fellowship of Weizmann Institute of Science, Israel’ and ‘PBC fellowship for outstanding post-doctoral researchers from China and India in Israeli universities’.

Alongside bench work, she authored more than 10 original research articles, all published in renowned international journals.

In 2016, she started working with a leading medical communication company and formally became a freelance science writer. Since then, she has engaged in writing a wide variety of scientific articles, including original research articles, review articles, science discoveries, popular science articles, and healthcare articles. Her first review article as a science writer was recently published in the journal ‘Oxidative Medicine and Cellular Longevity’.

Her work with News Medical offers a great platform for a wide range of audience to learn about the science behind good health.  

Articles from Sanchari Sinha

Unvaccinated and vaccinated have similar viral load in communities high in SARS-CoV-2 delta

Unvaccinated and vaccinated have similar viral load in communities high in SARS-CoV-2 delta

National Qatari study shows vaccination reduces risk of spreading SARS-CoV-2 infection

National Qatari study shows vaccination reduces risk of spreading SARS-CoV-2 infection

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Scientists develop a potent peptide inhibitor of SARS-CoV-2 in vitro

Scientists develop a potent peptide inhibitor of SARS-CoV-2 in vitro

Risk of myocarditis from SARS-CoV-2 infection is higher in young males, a study finds

Risk of myocarditis from SARS-CoV-2 infection is higher in young males, a study finds

Risk of venous thrombosis is higher in SARS-CoV-2 infection than vaccination

Risk of venous thrombosis is higher in SARS-CoV-2 infection than vaccination

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Spike-containing virus-like particles induce robust sterilizing immunity against SARS-CoV-2 in macaques

Spike-containing virus-like particles induce robust sterilizing immunity against SARS-CoV-2 in macaques

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection